Publications

5808 Results

Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group study

Authors
HB Grossman;CM Tangen;C Cordon-Cardo;R Cote;FM Waldman;RW De Vere White;AB Karnad;M Glode;ED Crawford
Journal / Conference
Oncology Reports 16:807-810
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9458

Adjuvant radiotherapy for pathologically-advanced prostate cancer: a randomized, clinical trial

Authors
IM Thompson;CM Tangen;J Paradelo;MS Lucia;G Miller;D Troyer;E Messing;J Forman;J Chin;G Swanson;E Canby-Hagino;ED Crawford
Journal / Conference
Journal of the American Medical Association 296(19):2329-2335
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Phase II trial of erlotinib in gastoresophageal junction and gastric adenocarcinomas: SWOG 0127

Authors
T Dragovich;S McCoy;CM Fenoglio-Preiser;J Wang;JK Benedetti;AF Baker;CB Hackett;SG Urba;KS Zaner;CD Blanke;JL Abbruzzese
Journal / Conference
Journal of Clinical Oncology 24(30):4922-4927
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
S0127

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I 131 Tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow up of Southwest Oncology Group protocol S9911

Authors
OW Press;JM Unger;RM Braziel;DG Maloney;TP Miller;M LeBlanc;RI Fisher
Journal / Conference
Journal of Clinical Oncology 24(25):4143-4149
Year
2006
Research Committee(s)
Lymphoma
Study Number(s)
S9911

Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group Phase II Trial (S0327)

Authors
PN Lara;K Chansky;AM Davies;WA Franklin;PH Gumerlock;PP Guaglianone;JN Atkins;NC Farneth;PC Mack;JJ Crowley;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 1(9):996-1001
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0327

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase

Authors
AR Kristal;C Chi;CM Tangen;PJ Goodman;R Etzioni;IM Thompson
Journal / Conference
Cancer 106(2):320-328
Year
2006
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Phase II trial of paclitaxel, carboplatin and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914

Authors
PJ Hesketh;J McCoy;FR DunphyII;JD Bearden III;GR Weiss;JK Giguere;JN Atkins;SR Dakhil;K Kelly;JJ Crowley;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 1(9):991-995
Year
2006
Research Committee(s)
Lung
Study Number(s)
S9914

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group trial 9346 (INT-0162)

Authors
M Hussain;CM Tangen;C Higano;PF Schellhammer;J Faulkner;ED Crawford;G Wilding;A Akdas;EJ Small;B Donnelly;G MacVicar;D Raghavan
Journal / Conference
Journal of Clinical Oncology 24(24):3984-3990
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

HER2 predicts benefit from adjuvant paclitaxel after AC in node-positive breast cancer: CALGB 9344.

Authors
DF Hayes;A Thor;L Dressler;D Weaver;G Broadwater;L Goldstein;S Martino;J Ingle;IC Henderson;D Berry
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#510
Year
2006
Research Committee(s)
Breast
Study Number(s)
SWOG-9410 (INT-0148) (CALGB-9344)

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma

Authors
TM Habermann;EA Weller;VA Morrison;RD Gascoyne;PA Cassileth;JB Cohn;SR Dakhil;B Woda;RI Fisher;BA Peterson;SJ Horning
Journal / Conference
Journal of Clinical Oncology 24(19):3121-3127
Year
2006
Research Committee(s)
Lymphoma
Study Number(s)
E4494